What is the recommended treatment approach for cicatricial (scarring) alopecia?

Cicatricial Alopecia Treatment

The primary goal in treating cicatricial (scarring) alopecia is early aggressive anti-inflammatory therapy to halt disease progression and prevent further permanent hair follicle destruction, as hair regrowth in already scarred areas is not possible 1, 2.

Critical Understanding

Cicatricial alopecias destroy hair follicles permanently through replacement with fibrous tissue. The therapeutic window is narrow—once scarring occurs, it's irreversible. Therefore, immediate intervention upon diagnosis is essential to preserve remaining follicles and prevent quality of life deterioration 3, 2.

Treatment Algorithm by Inflammatory Pattern

The North American Hair Research Society classifies primary cicatricial alopecias by their predominant inflammatory infiltrate, which directly guides treatment selection 1, 2:

Lymphocytic Cicatricial Alopecias (Lichen Planopilaris, Frontal Fibrosing Alopecia, Discoid Lupus Erythematosus)

First-line therapy:

• Topical corticosteroids (Class III-IV) combined with intralesional triamcinolone acetonide injections (10-20 mg/mL every 4-6 weeks) 1
• This combination addresses both surface and deeper follicular inflammation

Second-line systemic options:

• Hydroxychloroquine (200-400 mg daily) - particularly effective for lupus-related scarring alopecia 4
• Oral corticosteroids for acute flares
• Immunosuppressive agents (mycophenolate mofetil, methotrexate) for refractory cases

Emerging therapies showing promise:

• JAK inhibitors (baricitinib) - recent evidence suggests benefit but requires monitoring for immune suppression 4, 5
• TNF-α inhibitors and IL-17 inhibitors demonstrate potential for disease stabilization 5

Neutrophilic Cicatricial Alopecias (Folliculitis Decalvans, Dissecting Cellulitis)

First-line therapy:

• Combination of rifampicin (300 mg twice daily) with isotretinoin (0.5-1 mg/kg/day) - this addresses both the Staphylococcus aureus colonization and abnormal keratinization/inflammation 6
• This combination has shown remarkable outcomes even in treatment-resistant cases

Alternative antimicrobial approaches:

• Long-term tetracyclines (doxycycline 100 mg daily)
• Clindamycin with rifampicin combination
• Topical fusidic acid or mupirocin for localized disease

Mixed Pattern Alopecias

Require tailored combination therapy based on the predominant inflammatory component identified on biopsy 1.

Essential Diagnostic Steps

Before initiating treatment, confirm diagnosis with:

• Scalp biopsy (two 4mm punch biopsies: one for vertical sectioning, one for horizontal) - this is non-negotiable in unclear cases 1, 2
• Trichoscopy/dermoscopy to assess disease activity and differentiate from non-scarring conditions 7
• Look specifically for: absence of follicular openings, perifollicular erythema, follicular hyperkeratosis, and loss of follicular ostia

Critical Treatment Principles

1. Start treatment immediately upon diagnosis - every delay allows more irreversible follicular destruction 3, 2

2. Set realistic expectations - explain that treatment aims to:

   • Stop or slow progression
   • Reduce inflammation and symptoms (pain, burning, pruritus)
   • Preserve remaining hair follicles
   • NOT regrow hair in scarred areas 1

3. Monitor disease activity closely - assess every 3-4 months for:

   • Symptoms (burning, tenderness, pruritus)
   • Clinical signs of inflammation
   • Progression of hair loss
   • Trichoscopy findings

4. Address psychological impact - scarring alopecia significantly affects quality of life; offer psychological support and discuss camouflage techniques early 1, 2

Common Pitfalls to Avoid

• Delaying biopsy when diagnosis is uncertain - this delays appropriate treatment and allows progression
• Using only topical therapy for extensive or rapidly progressive disease - systemic therapy is often necessary
• Stopping treatment prematurely when inflammation appears controlled - maintenance therapy is typically required long-term
• Promising hair regrowth in scarred areas - this creates unrealistic expectations and patient dissatisfaction
• Ignoring the psychological burden - hair loss profoundly impacts self-image and requires holistic management

Adjunctive Measures

• Gentle hair care practices - avoid traction, harsh chemicals, and tight hairstyles
• Scalp hygiene - particularly important in neutrophilic alopecias
• Sun protection - for scalp areas with hair loss
• Camouflage options - wigs, hair fibers, scalp micropigmentation

Monitoring for Treatment Response

Success is defined as:

• Cessation of symptoms (no burning, itching, or tenderness)
• No new areas of hair loss
• Absence of inflammatory signs on examination
• Stable trichoscopy findings

If no response after 3-6 months of appropriate first-line therapy, escalate to second-line systemic agents or consider emerging biologics/JAK inhibitors 4, 5.